Reference is made to the Company's announcements made on 20 April 2020, 21 April 2020, 17 July 2020, 15 October 2020 and 18 January 2021 pertaining to the MOC between ATES, a wholly-owned subsidiary of ATS, and M3 Technologies (Asia) Berhad for the collaboration in the business relating to enhancements and value-added additions to ATES's anti-epidemic integrated disinfection chamber, including the software design and implementation to enable the fluid connectivity between all components. The Board of Directors of ATS announced that in light of the absence of any further progress on the MOC, the Parties have mutually agreed to terminate the MOC with immediate effect.